IGF1 and major depressive disorder: The enhancement of the peripheral IGF-1 expression in MDD may be a compensatory mechanism in response to its brain synthesis decrease (24) or diminished neurotrophin bioavailability due to the hyposensitivity of IGF-1 receptors under the neuroinflammatory stress (25).